Table 1 Comparison of clinical characteristics between the two groups
From: Clinical characteristics and risk factors associated with bone erosion in patients with tophi
Bone erosion | Non-Bone erosion | P value | |
|---|---|---|---|
N (male) | 135(132) | 75(69) | 0.104 |
Age (year) | 52.40 ± 14.32 | 46.33 ± 13.57 | 0.001 |
BMI (kg/m2) | 24.66 ± 3.49 | 25.60 ± 4.21 | 0.084 |
Gout duration (year) | 11.80 ± 6.31 | 9.13 ± 5.47 | 0.001 |
Tophi duration (year) | 5.44 ± 3.86 | 3.55 ± 4.12 | <0.001 |
GFR (ml/min/1.73m2) | 61.61 ± 24.10 | 68.85 ± 21.98 | 0.033 |
Hypertension, n (%) | 39 | 39 | 0.983 |
Diabetes, n (%) | 9 | 15 | 0.199 |
Smoking history, n (%) | 52 | 39 | 0.067 |
Drinking history, n (%) | 41 | 23 | 0.008 |
Ulceration, n (%) | 29 | 12 | 0.005 |
WBC count (10^9/mL) | 10.79 ± 12.16 | 8.81 ± 2.72 | 0.261 |
PLT count (10^9/mL) | 312.67 ± 112.32 | 297.48 ± 95.17 | 0.659 |
HGB (g/L) | 128.04 ± 24.14 | 130.59 ± 19.23 | 0.708 |
ALT (U/L) | 31.13 ± 25.07 | 32.84 ± 24.22 | 0.367 |
sUA (mg/dl) | 9.53 ± 1.94 | 9.45 ± 2.34 | 0.756 |
sCr (mg/dl) | 1.54 ± 0.55 | 1.33 ± 0.39 | 0.001 |
CRP (mg/L) | 30.47 ± 38.03 | 32.26 ± 41.79 | 0.919 |
ESR (mm/h) | 48.08 ± 36.50 | 47.86 ± 32.69 | 0.664 |